New marker may help diagnose late-stage lung cancer

Download PDF Copy

Editorial Checklist

Reviewed

Jul 10 2017

NewsGuard 100/100 Score

Investigators have found a new marker that might be used for diagnosing a common form of lung cancer, especially at late stages.

High expression of this marker, which is a particular circular RNA, in blood and lung cancer tissue was linked with increased cell proliferation, migration, and invasion, which are characteristics necessary for tumor growth and metastasis.

Source:

http://newsroom.wiley.com/press-release/febs-journal/marker-may-improve-lung-cancer-screening-and-detection

Posted in: Medical Science News | Medical Research News | Medical Condition News

Tags: Acanthosis Nigricans, B Cell, Blood, Body Mass Index, Cancer, Cell, Cell Proliferation, Children, Exercise, Lung Cancer, Metastasis, Obesity, Proliferation, RNA, Skin, T-Cell, Tumor, Weight Loss, X-linked

Comments (0)

Download PDF Copy

Suggested Reading

Study shows AI can predict prognosis in triple-negative breast cancer

Study shows AI can predict prognosis in triple-negative breast cancer

AI-powered tool predicts gene activity in cancer cells from biopsy images

AI-powered tool predicts gene activity in cancer cells from biopsy images

AI models redefine TIL scoring in breast cancer but face challenges in real-world validation

AI models redefine TIL scoring in breast cancer but face challenges in real-world validation

Air pollution linked to head and neck cancer risk

Air pollution linked to head and neck cancer risk

Researchers uncover key genes linked to DCIS progression

Researchers uncover key genes linked to DCIS progression

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients

Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients

Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy

Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Study shows cannabis as a genotoxic substance with cancer risks